Literature DB >> 32484592

Silencing of spontaneous activity at α4β1/3δ GABAA receptors in hippocampal granule cells reveals different ligand pharmacology.

Nils Ole Dalby1, Christina Birkedahl Falk-Petersen1, Ulrike Leurs1, Petra Scholze2, Jacob Krall1, Bente Frølund1, Petrine Wellendorph1.   

Abstract

BACKGROUND AND
PURPOSE: The δ-subunit-containing GABAA receptors, α4 β1 δ and α4 β3 δ, in dentate gyrus granule cells (DGGCs) are known to exhibit both spontaneous channel openings (i.e. constitutive activity) and agonist-induced current. The functional implications of spontaneous gating are unclear. In this study, we tested the hypothesis that constitutively active α4 β1/3 δ receptors limit agonist efficacy. EXPERIMENTAL APPROACH: Whole-cell electrophysiological recordings of adult male rat and mouse hippocampal DGGCs were used to characterize known agonists and antagonists at δ-subunit-containing GABAA receptors. To separate constitutive and agonist-induced currents, different recording conditions were employed. KEY
RESULTS: Recordings at either 24°C or 34°C, including the PKC autoinhibitory peptide (19-36) intracellularly, removed spontaneous gating by GABAA receptors. In the absence of spontaneous gating, DGGCs responded to the α4 β1/3 δ orthosteric agonist Thio-THIP with a four-fold increased efficacy relative to recording conditions favouring constitutive activity. Surprisingly, the neutral antagonist gabazine was unable to antagonize the current by Thio-THIP. Furthermore, a current was elicited by gabazine alone only when the constitutive current was silenced (EC50 2.1 μM). The gabazine-induced current was inhibited by picrotoxin, potentiated by DS2, completely absent in δ-/- mice and reduced in β1 -/- mice, but could not be replicated in human α4 β1/3 δ receptors expressed heterologously in HEK cells. CONCLUSION AND IMPLICATIONS: Kinase activity infers spontaneous gating in α4 β1/3 δ receptors in DGGCs. This significantly limits the efficacy of GABAA agonists and has implications in pathologies involving aberrant excitability caused by phosphorylation (e.g. addiction and epilepsy). In such cases, the efficacy of δ-preferring GABAA ligands may be reduced.
© 2020 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32484592      PMCID: PMC7429488          DOI: 10.1111/bph.15146

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  47 in total

1.  Animal research: reporting in vivo experiments: the ARRIVE guidelines.

Authors:  Carol Kilkenny; William Browne; Innes C Cuthill; Michael Emerson; Douglas G Altman
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

2.  Activity-dependent tuning of inhibitory neurotransmission based on GABAAR diffusion dynamics.

Authors:  Hiroko Bannai; Sabine Lévi; Claude Schweizer; Takafumi Inoue; Thomas Launey; Victor Racine; Jean-Baptiste Sibarita; Katsuhiko Mikoshiba; Antoine Triller
Journal:  Neuron       Date:  2009-06-11       Impact factor: 17.173

3.  GABA(A) receptor subunits in the rat hippocampus I: immunocytochemical distribution of 13 subunits.

Authors:  G Sperk; C Schwarzer; K Tsunashima; K Fuchs; W Sieghart
Journal:  Neuroscience       Date:  1997-10       Impact factor: 3.590

4.  Spontaneously opening GABA(A) channels in CA1 pyramidal neurones of rat hippocampus.

Authors:  B Birnir; A B Everitt; M S Lim; P W Gage
Journal:  J Membr Biol       Date:  2000-03-01       Impact factor: 1.843

5.  Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers.

Authors:  Michael J Curtis; Steve Alexander; Giuseppe Cirino; James R Docherty; Christopher H George; Mark A Giembycz; Daniel Hoyer; Paul A Insel; Angelo A Izzo; Yong Ji; David J MacEwan; Christopher G Sobey; S Clare Stanford; Mauro M Teixeira; Sue Wonnacott; Amrita Ahluwalia
Journal:  Br J Pharmacol       Date:  2018-04       Impact factor: 8.739

6.  Regulation of GABAergic synapse formation and plasticity by GSK3beta-dependent phosphorylation of gephyrin.

Authors:  Shiva K Tyagarajan; Himanish Ghosh; Gonzalo E Yévenes; Irina Nikonenko; Claire Ebeling; Cornelia Schwerdel; Corinne Sidler; Hanns Ulrich Zeilhofer; Bertran Gerrits; Dominique Muller; Jean-Marc Fritschy
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-20       Impact factor: 11.205

7.  GABAA receptor alpha 4 subunits mediate extrasynaptic inhibition in thalamus and dentate gyrus and the action of gaboxadol.

Authors:  D Chandra; F Jia; J Liang; Z Peng; A Suryanarayanan; D F Werner; I Spigelman; C R Houser; R W Olsen; N L Harrison; G E Homanics
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-27       Impact factor: 11.205

8.  Probing α4βδ GABAA receptor heterogeneity: differential regional effects of a functionally selective α4β1δ/α4β3δ receptor agonist on tonic and phasic inhibition in rat brain.

Authors:  Kirsten Hoestgaard-Jensen; Nils Ole Dalby; Jacob Krall; Harriet Hammer; Povl Krogsgaard-Larsen; Bente Frølund; Anders A Jensen
Journal:  J Neurosci       Date:  2014-12-03       Impact factor: 6.167

9.  A-kinase anchoring protein 79/150 facilitates the phosphorylation of GABA(A) receptors by cAMP-dependent protein kinase via selective interaction with receptor beta subunits.

Authors:  Nicholas J Brandon; Jasmina N Jovanovic; Marcie Colledge; Josef T Kittler; Julia M Brandon; John D Scott; Stephen J Moss
Journal:  Mol Cell Neurosci       Date:  2003-01       Impact factor: 4.314

10.  Assembly rules for GABAA receptor complexes in the brain.

Authors:  James S Martenson; Tokiwa Yamasaki; Nashid H Chaudhury; David Albrecht; Susumu Tomita
Journal:  Elife       Date:  2017-08-17       Impact factor: 8.140

View more
  3 in total

1.  Silencing of spontaneous activity at α4β1/3δ GABAA receptors in hippocampal granule cells reveals different ligand pharmacology.

Authors:  Nils Ole Dalby; Christina Birkedahl Falk-Petersen; Ulrike Leurs; Petra Scholze; Jacob Krall; Bente Frølund; Petrine Wellendorph
Journal:  Br J Pharmacol       Date:  2020-07-15       Impact factor: 8.739

2.  Effective Activation by Kynurenic Acid and Its Aminoalkylated Derivatives on M-Type K+ Current.

Authors:  Yi-Ching Lo; Chih-Lung Lin; Wei-Yu Fang; Bálint Lőrinczi; István Szatmári; Wan-Hsuan Chang; Ferenc Fülöp; Sheng-Nan Wu
Journal:  Int J Mol Sci       Date:  2021-01-28       Impact factor: 5.923

3.  Preventing Phosphorylation of the GABA A R β3 Subunit Compromises the Behavioral Effects of Neuroactive Steroids.

Authors:  Thuy N Vien; Michael A Ackley; James J Doherty; Stephen J Moss; Paul A Davies
Journal:  Front Mol Neurosci       Date:  2022-03-31       Impact factor: 6.261

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.